AKT1 and breast carcinoma: While PI3K-AKT signalling plays a critical role in breast cancer, a complex network of genetic alterations, and secondary or complimentary signalling and regulatory mechanisms that control pathway activity also influence benefit to different PI3K therapeutic approaches targeting this pathway9,10.